Hecate Grid's L.A. County Energy Storage Project Achieves Key Milestones
/PRNewswire/ -- Hecate Grid, an independent power producer focused on developing, building, owning and operating stand-alone energy storage projects in the...
Stay updated with breaking news from Hecate Grid. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Hecate Grid, an independent power producer focused on developing, building, owning and operating stand-alone energy storage projects in the...
Repsol has signed an agreement to acquire 40% of Hecate Energy, a U.S. company specializing in the development of PV solar and battery projects for energy storage. This transaction is Repsol's first foray into the U.S. renewables market.
Repsol enters US renewables market with investment in solar developer Hecate Energy Email Repsol will have the option of buying the remainder of Hecate three years after the initial deal closes. Image: Repsol/Flickr. Spanish oil major Repsol has made its first foray into the US renewables market with the acquisition of a 40% stake in solar and energy storage project developer Hecate Energy. Repsol, which will have the option of buying the remaining shares three years after the deal closes, said the transaction will make it a “significant player” in the US solar develop...
13 May 2021 8:10 GMT Updated 13 May 2021 10:08 GMT in Perth Spanish giant Repsol has made its first entry into the US renewables market via the acquisition of a 40% interest in solar and battery storage project developer Hecate Energy. ENERGY EXPLORED: SUBSCRIBE TO ACCELERATE Gain valuable insight into the global oil and gas industry's energy transition from Repsol did not provide financial details of the transaction, however, it noted it also had the option to acquire Hecate’s outstanding shares three years after the closing of the deal. Hecate holds a portfolio of more th...
SEATTLE, Jan. 07, 2021 -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore